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Abstract
Environmental tobacco smoke (ETS) is a major contributor to indoor air pollution. Since decades it is well
documented that ETS can be harmful to human health and causes premature death and disease. In comparison to
the huge research on toxicological substances of ETS, less attention was paid on the concentration of indoor ETS-
dependent particulate matter (PM). Especially, investigation that focuses on different tobacco products and their
concentration of deeply into the airways depositing PM-fractions (PM10, PM2.5 and PM1) must be stated. The
tobacco smoke particles and indoor air quality study (ToPIQS) will approach this issue by device supported
generation of indoor ETS and simultaneously measurements of PM concentration by laser aerosol spectrometry.
Primarily, the ToPIQ study will conduct a field research with focus on PM concentration of different tobacco
products and within various microenvironments. It is planned to extend the analysis to basic research on
influencing factors of ETS-dependent PM concentration.
Introduction
The supply of clean air is regarded as one of the most
important basic factors for the human health and well-
being. In consequence, polluted air is able to threat
human health and is considered as a major global health
problem [1]. According to an estimation of the WHO
(World Health Organization) approximately 2 million
premature deaths worldwide per year are caused by air
pollution [2]. Especially the quality of indoor air is of
utmost importance for human health. Not only because
people spend most of their time indoors (in industria-
lized countries, as the USA, up to almost 90 percent [3])
but also because the indoor concentration of pollutants
is often much higher [4]. The wide range of indoor pol-
lutants contains organic or inorganic chemicals, biologi-
cal aerosols (bioaerosols) and particles. A major source
of indoor air pollution is the environmental tobacco
s m o k e( E T S ,a l s oc a l l e ds e c o n dh a n ds m o k e )[ 5 - 7 ] ,
which is a mixture of exhaled mainstream smoke (MS)
and sidestream smoke (SS) released from the smoulder-
ing tobacco product. Since decades it is well documen-
ted that ETS can be harmful to human health and
causes premature death and disease to the non-smoking
population [8]. Especially ETS exposed children have an
increased risk for acute respiratory infections, sudden
infant death syndrome, more severe asthma and ear pro-
blems [6,8]. In the adult population, exposure to ETS is
associated with acute coronary heart disease [9-11] and
lung cancer [12,13]. According to a 2004 published esti-
mation by Öberg et al., almost half of the world’sc h i l -
dren (approx. 40%) are regularly exposed to ETS
followed by nonsmoking women (35%) and men (33%)
[14]. Although exposure to ETS appears to present
smaller risks than active smoking, the large percentage
of exposed people, coupled with evidences that ETS
causes illness and premature death, demonstrates a sub-
stantial public health threat. Because of these adverse
effects to human health, tobacco smoke has been inten-
sely investigated. To date, about 5000 individual com-
pounds have been quantitatively determined in cigarette
smoke [15], including many toxic substances as well as
69 carcinogens, of which 11 are known human carcino-
gens and 7 are probably carcinogenic in humans [16].
Many of these toxic and carcinogenic substances can be
found in ETS as well. Particulate matter (PM) is one of
those harmful components that can be found in ETS
and is responsible for ETS as a substantial contributor
to the level of particulate indoor air pollution [17].
Because of their capability to deposit deeply in the
respiratory tract, particles of the PM10- and PM2.5-
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time, PM10 and PM2.5 have been proven to be asso-
ciated with acute and chronic health effects. Epidemiolo-
gical data suggesting that exposure to particle pollution
(PM10 and PM25) is able to increase morbidity and
mortality of cardiopulmonary diseases like pre-existing
COPD [18-23], cardiovascular diseases [24-26], exacer-
bation of asthma [20,27,28] and other conditions [29].
In addition, exposure to PM and especially to PM2.5
has been linked to the development of cancer [30].
However, the exact mechanism of cancer induction due
to PM is still not resolved. Regarding the impact of both
ETS and PM on human health, only few data is pub-
lished about the concentration of PM in ETS so far.
Aims
It is the aim of the ToPIQ study to assess the particle
concentrations (PM10, PM2.5 and smaller particle frac-
tions) that are produced by different tobacco products
under a multitude of different conditions. Next to the
determination of ETS-dependent PM concentrations
within various microenvironments, like vehicle cabins,
t h i ss t u d ya i m st oe x a m i n et h er o l eo fp h y s i c a li n f l u e n -
cing factors on the PM concentration.
Methods
For the implementation of the ToPIQ study (ToPIQS),
generation of ETS it will be necessary. To avoid health
risks on human smokers a self-made ETS emitter
(ETSE) will be used for the indoor ETS generation (Fig-
ure 1). Basically, the ETSE consists of a bag valve mask
(BVM) plus tubing by which MS from the burning
cigarette can be collected and afterwards vented out
into the testing chamber. Throughout the experiment
the burning tobacco product will be situated inside the
testing chamber, producing the SS in between the time
of MS collection. When the bag is inflating it collects
the smoke inside. During the compression of the bag,
the smoke will be released in the chamber. The com-
pression and decompression of the bag will follow a pre-
defined protocol under support of acoustic signals. The
hand-operating ETSE will be attached outside of the
chamber. There, the researcher can operate the device
without the potential harm of an ETS exposure. Glove
ports on the outside of the chamber will provide an iso-
lated access to the chamber (Figure 1). In the future, the
implementation of an automatic ETSE (AETSE) in the
study is planned. With this device, simulations of ETS
emitted by multiple smokers will be conducted.
The experiments will be carried out in different micro-
environments. For the basic research on ETS of different
tobacco types, a 1.75 m
3 telephone cabin will be used as
an ETS test chamber (Figure 2). To simulate natural con-
ditions the test chamber will be placed on an outdoor
area in urban surrounding. Inside the chamber, mobile
sensing modules will be placed, which will continuously
measure the concentration of particulate matter (PM10,
PM2.5 and PM1) and physical parameters (temperature,
humidity, wind velocity). Subsequently, the measured
data will be saved on an ultra-mobile PC unit. The gen-
eration of indoor ETS will be performed by the ETSE.
Monitoring will be carried out in different ventilation
modes with open and closed windows. In a next step,
basic studies on the effect of volume size will be con-
ducted on self-constructed testing chambers with a sizes-
range of some cubic centimeters to several cubic meters.
To study the effect of physical parameters on ETS parti-
cle concentration, the environmental conditions in these
chambers will be kept stable. In future setups it is
planned to investigate microenvironments of various
vehicle cabins. Similar to the procedure at the testing
cabin, mobile sensing modules will be monitoring PM
and physical parameters inside the vehicle during ETS
generation by the ETSE. The measurements will take
Figure 1 Picture taken from outside of the testing chamber
(telephone cabin) showing the ETSE (1) and the glove ports (2).
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ent window positions and different air vent or air-condi-
tioning modes on the particle concentration of PM10,
PM2.5 and PM1. To study the influence of different driv-
ing conditions on the particle concentration, they will be
simulated in stationary cars with the help of ventilators.
In each testing chamber, the mobile sensing module will
be mounted inside the chamber at a location where chil-
dren are potentially exposed to ETS. To create compar-
able settings, all conditions (ETS generation, test
chamber, measurement) will be standardized. Prior to
every sequence, a 20-minute background collection of
the PM-concentration will be performed. Since a part of
the sampling will be taken outdoors, it is important to
prevent data bias due to environmental factors. There-
fore, the measurements of the different tobacco products
or cigarette brands will be measured alternately with a
reference cigarette. To avoid bias due to daily variation of
PM concentration, a data correction will be performed.
For that reason, values of the prior collected average PM
background concentration will be subtracted from the
measured data during and after the ETS emission.
Initially, the received basic data from the measure-
ments will be processed. Each average background
concentration will then be subtracted from the concen-
tration of the following ETS measurement to avoid bias
from daily variation of PM concentration. The obtained
data of the different sensors will be integrated. Subse-
quently, the data of every measurement will be divided
in the two intervals “ETS emission” and “ETS elimina-
tion”.T h ei n t e r v a l“ETS emission” will represent the
phase of ETS generation and the interval “ETS emis-
sion” will outline the time where the ETS concentration
will be reduced due to processes of ventilation and
deposition. For both intervals and for every PM-fraction
the arithmetic mean (Cmean-PM), the maximum concen-
tration (Cmax-PM), and the area under the curve (AUC-
PM) will be calculated. Following data processing, an
exploratory data analysis will be carried out. Data pro-
cessing and analysis will be performed using specific cal-
culating and statistical software.
Discussion
So far, large scale assessment of PM generation by
tobacco products was not performed. Therefore, only
little data is available in scientific databases such as
PubMed, Medline or ISI-Web. Novel approaches includ-
ing scientometric and visualizing techniques are not
applicable [31-43] and the few existing studies can easily
be summarized. Early researches of particulate matter
concentration in ETS focused on respirable suspended
particle mass (RSP) [44-47]. Distinction between differ-
ent PM-fraction (PM10, PM2.5, and PM1) and cigarette
brands, as planned in the ToPIQ study, however, were
not made. Since two of these published articles were
conducted or supported by cigarette companies [44,45]
the impartiality of these results is at least debatable. In
most of these studies the ETS generation was carried
out by human smokers in special testing chambers with
a capacity of 18 to 45 m
2 [44,45,47]. Although realistic
ETS generation can be guaranteed by using human smo-
kers, this approach is dangerous to human health and
therefore unethical. That is why an ETSE or AETSE will
be used in the ToPIQ study. Other studies undertaken
in the last decade focused on the ETS-dependent emis-
sions of PM10 or PM2.5 or both [48-53], but of these
studies only three investigated specific cigarette brands
as planned in the ToPIQ study [48,50,51]. Only two of
these studies were performed without human smokers
by using smouldering cigarettes [48,51]. However, the
usage of smouldering cigarettes for the ETS generation
is insufficient since smouldering cigarettes can only pro-
duce SS and no MS. That is why the emissions gener-
ated by this method are not comparable to ETS
emissions. To simulate ETS for the research in the
ToPIQ study, we will use ETSE or AETSE, which are
capable of generating SS as well as MS and therefore
the two major components of ETS.
Figure 2 Testing chamber (telephone cabin) with outside
mounted ETSE (E).
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The ToPIQ study will serve as a new platform to inves-
tigate ETS-dependent particulate matter of different
tobacco products and within variable microenviron-
ments. Using the knowledge of this platform, further
studies may focus on mechanisms by which particulate
matter harms the human body, i.e. with the use of mod-
ern techniques of toxicology [54,55], molecular biology
[56-60] and biochemistry [61-64].
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